ondansetron has been researched along with Arthritis, Juvenile Chronic in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rheumatoid arthritis, Methotrexate, Ondansetron, Nausea, Arthritis juvenile." | 4.12 | Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis. ( Fida, S; Kakalia, S; Khan, HA; Kitchlew, R; Saif, S; Siddique, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saif, S | 1 |
| Kakalia, S | 1 |
| Kitchlew, R | 1 |
| Khan, HA | 1 |
| Fida, S | 1 |
| Siddique, M | 1 |
1 other study available for ondansetron and Arthritis, Juvenile Chronic
| Article | Year |
|---|---|
Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Humans; Methotrexate; Nausea; Onda | 2022 |